600267.SH
Zhejiang Hisun Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 12.06
−7.80%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenCNY 11.45
From 52W high−16.08%
Volume20.33M
Market capCNY 14.23B
P/E (TTM)26.3x
P/S (TTM)1.3x
Div yield1.85%
Key dataSep 18, 2026
Open
CNY 11.45
From 52W high
−16.08%
Volume
20.33M
Market cap
CNY 14.23B
ValuationView details →
P/E (Fwd)
22.3x
EV/EBITDA
7.2x
P/E (TTM)
26.3x
RSI (14)
40.4
MomentumView details →
1D Return
−7.80%
YTD Return
+15.07%
Similar companies
Latest newsMore news →
Zhejiang Hisun Animal Health Products, a controlled subsidiary of Hisun Pharmaceutical, received approval from the Ministry of Agriculture and Rural Affairs for a compound fipronil-praziquantel-moxidectin spot-on veterinary drug product, valid from September 10, 2026 to September 9, 2031.6d agoHisun Pharmaceutical's subsidiary Zhejiang Hisun Animal Health Products received a new veterinary drug registration certificate for a compound fipronil/praziquantel/moxidectin drop product for cats, and the product is ready for production and market launch.13d agoHisun Pharmaceutical signed a strategic cooperation agreement with Chengdu Xingji Space Exploration Technology Co., Ltd. (Xingji Development) to enter the space biopharmaceutical sector.24d ago